Hussein-Fikret S, Fuller P J
Prince Henry's Institute of Medical Research, PO Box 5152, Clayton, Vic. 3168, Australia; Monash University Department of Medicine, Monash Medical Centre, Clayton, Vic. 3168, Australia.
Mol Cell Endocrinol. 2005 Jan 14;229(1-2):149-60. doi: 10.1016/j.mce.2004.08.005.
Granulosa cell tumours of the ovary (GCT) exhibit high expression of estrogen receptor beta (ERbeta). A role for estrogen receptors in these tumours may depend on altered co-activator expression. This study examines the expression of the co-activators SRC-1a/e, SRC-2, SRC-3, SRA, and the corepressors NCoR and SMRT in GCT, epithelial ovarian tumours and normal ovary. No significant difference in the expression of SRC-1, SRC-2, SRC-3 or NCoR and SMRT was found. In particular, there was no correlation of co-activator expression with ERbeta expression. There was a significant upregulation in the expression of the novel RNA co-activator SRA in the serous tumours compared with the other tumour types and normal ovary. The findings suggest that ERbeta may require co-activators, other than members of the SRC family for the modulation of transcription in GCT.
卵巢颗粒细胞瘤(GCT)表现出雌激素受体β(ERβ)的高表达。雌激素受体在这些肿瘤中的作用可能取决于共激活因子表达的改变。本研究检测了共激活因子SRC-1a/e、SRC-2、SRC-3、SRA以及共抑制因子NCoR和SMRT在GCT、上皮性卵巢肿瘤和正常卵巢中的表达。未发现SRC-1、SRC-2、SRC-3或NCoR和SMRT的表达有显著差异。特别是,共激活因子表达与ERβ表达之间没有相关性。与其他肿瘤类型和正常卵巢相比,浆液性肿瘤中新型RNA共激活因子SRA的表达有显著上调。研究结果表明,在GCT中,ERβ可能需要SRC家族成员以外的共激活因子来调节转录。